What Clinicians Should Know About Johnson & Johnson Janssen COVID-19 Vaccine

This COCA Call will give clinicians an overview of the J&J Janssen COVID-19 vaccine. Clinicians will learn about vaccine characteristics and administration, vaccinating special populations, and contraindications. They will also get answers to a number of clinical questions CDC has received about this new vaccine.

Comments on this video are allowed in accordance with our comment policy:
http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html

This video can also be viewed at

Recommend0 recommendationsPublished in US National Health Agency Sources

Related Articles

5 Essential Frameworks for Preventing Violent Child Death

The U.S. has a violent child death problem. Developing strategies to prevent violent child deaths death from firearms and traffic crashes is a demanding task that requires consideration of numerous upstream, interrelated, and tangential issues. To help safety advocates develop strategies to prevent violent child death, we compiled five frameworks to help: Understand and explain …
The post 5 Essential Frameworks for Preventing Violent Child Death appeared first on Salud America.

Latino ‘Excess Deaths’ Far Exceed Initial Estimates during COVID-19 Pandemic

Annually, CDC researchers compile and analyze data to predict the number of deaths that will occur in the coming year. The number of mortalities that go over this initial estimate, or “the difference between the observed numbers of deaths in specific time periods and expected numbers of deaths in the same time periods,” are known …
The post Latino ‘Excess Deaths’ Far Exceed Initial Estimates during COVID-19 Pandemic appeared first on Salud America.

Responses